Pitt innovators were issued 6 U.S. patents in August 2024.
Featured patent: 12,064,532: “Ovarian Derived Hydrogels for Biomedical and Biotechnology Application”
Women cancer survivors often struggle with infertility and reproductive dysfunction. Pitt innovators are developing a novel method to support follicle development and restore fertility after chemotherapy utilizing a biomaterial derived from decellularized porcine ovarian tissues. The resultant ovarian-specific hydrogel has been shown to support in vitro follicle development after targeted delivery in to the ovarian cortex via microinjection.
For more information on this technology, including licensing, contact us at partner@pitt.edu.
Below is a listing of all patents issued to Pitt innovators in August 2024. You can also search all Pitt technologies available for licensing.
| Patent Number |
Title | Inventor(s) | Licensing Manager | Status | |||
| 12,064,532 | Ovarian Derived Hydrogels for Biomedical and Biotechnology Applications | Bryan Brown; Michael Buckenmeyer; Aleksander Rajkovic; Yonghyun Shin | Janice Panza | Available for Licensing | |||
| 12,059,434 | Short-Term Activated DC12 and Methods for Their Production and Use | Pawel Kalinski | Andrew Remes | Licensed | |||
| 12,070,530 | Decellularization and Functionalization of Extracellular Matrix Biomaterials | Bryan Brown; Samuel LoPresti | Janice Panza | Available for Licensing | |||
| 12,070,475 | Extracts for the Regeneration of Ligaments | Ricardo Gottardi; Shinsuke Kihara; Benjamin Rothrauff; Rocky Tuan | Janice Panza | Available for Licensing | |||
| 12,065,409 | Analogs of 2-Pralidoxime as Antidotes Against Organophosphorus Nerve Agents | Kiflai Bein; Robert Bressin; James Burrows; Adriana Gambino; Kazunori Koide; George Leikauf; Dianne Pham | Maria Vanegas | Available for Licensing | |||
| 12,070,294 | Endovascular Orifice Detection Device for Accurate Fenestrated Stent Graft Deployment | Timothy Chung; Mohammad Eslami; David Vorp | Janice Panza | Available for Licensing |